
    
      All subjects will receive a single dose of GSK Biologicals' Mencevax ACWY vaccine according
      to the prescribing information. Subjects will be stratified into the following age groups:

      2 to 5 years 6 to 17 years > 18 years The Protocol Posting has been updated in order to
      comply with the FDA Amendment Act, September 2007.
    
  